Articles
January, 2021
White Paper: Conducting Safe and Effective Clinical Trials in the COVID-19 Environment
Read More »
December, 2020
Increasing Your Practice’s Reach, Relevance, and Revenue with Clinical Trials
Read More »
November, 2020
White Paper: The Patient Perspective on Living with Glaucoma
Read More »News
December, 2020
Oyster Point Pharma Submits New Drug Application to the U.S. Food and Drug Administration for OC-01 (varenicline) Nasal Spray for the Treatment of Signs and Symptoms of Dry Eye Disease
Read More »
December, 2020
Palatin Technologies Announces Positive Results From its Phase 2 Study of PL9643 in Patients with Dry Eye Disease
Read More »
December, 2020